Before you sell to, join or invest in BioDelivera
MentionFox check on BioDelivera: only 1 source on file so far (checked 9 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/yc-biodelivera
Check BioDelivera before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
BioDelivera has developed proprietary GCV™, a drug delivery platform designed to travel through the body and selectively target diseased cells while sparing healthy ones. GCVs can carry genetic medicines, DNA, RNA, small molecules, or combinations of these at the same time.
BioDelivera is a Y Combinator company in the Fall 2026 batch. Its directory entry describes it as: Programmable drug delivery precisely targets only diseased cells. The founders listed are Ikeda Trashi (Founder/CEO), Orikeda Trashi (Founder/President) (Y Combinator directory entry, November 8, 2026).
Sell to companies like BioDelivera? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New accelerator entry · 2026-11-08 · the record
Pitching, partnering or investing alongside them? See who really runs and owns BioDelivera.
Free to see. No signup.
More on BioDelivera and the records around it.
Same batch, Healthcare first.
Get an email when BioDelivera changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when BioDelivera raises, hires or launches. No email unless you switch it on.
Watch BioDelivera →Get the full cited report on BioDelivera
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on BioDelivera: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
BioDelivera has developed proprietary GCV™, a drug delivery platform designed to travel through the body and selectively target diseased cells while sparing healthy ones. GCVs can carry genetic medicines, DNA, RNA, small molecules, or combinations of these at the same time. BioDelivera has demonstrated efficacy in tumors, muscle, and brain and is expanding to additional tissues. The company’s mission is to enable cures for every patient, across every disease.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on BioDelivera: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on BioDelivera covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist BioDeliveraYou get an alert in MentionFox the next time this company shows up.
If you're behind BioDelivera: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.
Each opens in a new tab, filled in for BioDelivera. With no account yet, you sign up free and land on the result.
Share the news. Sharing needs no account.
https://mentionfox.com/funding/yc-biodelivera